An international team of researchers have introduced a groundbreaking drug, known as the covalent kinase inhibitor, which shows promise in combating treatment-resistant malaria.Developed by chemists ...

Enzyme designers in the David Baker lab at the University of Washington in Seattle, from left: Sam Pellock, Anna Lauko, Kiera ...

Nobel Laureate Prof. Aaron Ciechanover (2004, Chemistry) delivered a special address at the inaugural of ProUPS (Proteostasis ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Liverpool researchers' discovery of collagen in fossilized bones could provide new insights into dinosaurs. For years, ...

High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...

EPFL scientists have identified a new property, interface flexibility, that controls how certain molecules naturally ...

High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing more of a specific protein, even proteins that would normally destroy them, ...